Human receptor tyrosine kinase, KDR

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S069100, C435S069700, C435S183000, C435S252300, C435S254110, C530S350000, C536S023500, C536S023400

Reexamination Certificate

active

06841382

ABSTRACT:
An isolated nucleic acid molecule encoding a novel human receptor type tyrosine kinase gene, KDR, is disclosed. The isolation of this KDR cDNA sequence results in disclosure of purified forms of human KDR protein, recombinant vectors and recombinant hosts which express human KDR.

REFERENCES:
patent: 5240848 (1993-08-01), Keck et al.
patent: 5332671 (1994-07-01), Ferrara et al.
patent: 5766860 (1998-06-01), Terman et al.
patent: 5861301 (1999-01-01), Terman et al.
patent: 0 506 477 (1992-03-01), None
patent: WO 9214748 (1992-09-01), None
patent: WO 9214748 (1992-09-01), None
patent: WO 9411499 (1994-05-01), None
Ferrara, N. et al; The Vascular Endothelial Growth Factor Family of Polypeptides; Journal of Cellular Biochemistry, vol. 47; 1991; pp. 211-218.
Maglione, D. et al; Two Alternative mRNAs coding for the angiogenic factor, placenta growth factor (PIGF), Are Transcribed from a Single Gene of chromosome 14; Oncogene; vol. 8, 1993, p. 925-931.
Hauser, S. et al.; A Heparin-Binding Form of Placenta; Growth Factor (PIGF-2) is Expressed in Human Umbilical Vein Endothelial Cells and in Placenta; Growth Factors; vol. 9, 1993; pp. 259-268.
Grimmond, S. et al; Cloning and Characterization of a Novel Human Gene Related to Vascular Endothelial Growth Factor; Genome Research; vol. 6, 1996; pp. 124-131.
Olofsson, B. et al; Vascular Endothelial Growth Factor B, A Novel Growth Factor for Endothelial cells; Proc. Natl. Acad Sci. USA, vol. 93, 1996; pp. 2576-2581.
Joukov, V. et al; A Novel Vascular Endothelial Growth Factor, VEGF-C is a Ligand for the FLT (VEGFR-3) and KDR (VEGFR-2) Receptor Tyrosine Kinases; The EMBO Journal; vol. 15; No. 2; 1996; pp. 290-298.
Shibuya, M. et al. Nucleotide Sequence and Expression of a Novel Human Receptor-Type Tyrosine Kinase Gene (FLT) closely Related to the fms Family; Oncogene; vol. 5, 1990, pp. 519-524.
Pajusola, K. et al, FLT4 Receptor Tyrosine Kinase Contains Seven Immunoglobin-like Loops and Is Expressed in Multiple Human Tissues and Cell Lines; Cancer Research; vol. 52, 5738-5743.
Terman, B.I. et al; Identification of a New Endothelial Cell Growth Factor Receptor Tyrosine Kinase; Oncogene; vol. 6, 1991, pp. 1677-1683.
Terman, B.J. et al; Identification of the KDR Tyrosine Kinase as a Receptor for Vascular Endothelial Cell Growth Factor, Biochemical & Biophysical Research Communications; vol. 187, No. 3; 1992, pp. 1579-1586.
Rockwell et al. ‘In Vitro Neutralization . . . Monoclonal Antibody’, Mol. Cell Differ., vol. 3(1), pp. 91-109 (1995).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Human receptor tyrosine kinase, KDR does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human receptor tyrosine kinase, KDR, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human receptor tyrosine kinase, KDR will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3395856

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.